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a greater increase in LVEF in 66 pts (from !Zyo to 63%) than did no P in
65 pte (from 58% to 60%) (p < 0.0001). At 1 year, P caused a greater
decrease in left ventricular mass (from 312 g to 276 g) than did no P
(from 317 g to 297 g) (p = 0.0001). Multivariate Cox regression analysis
for mortality including variables age, sex, hypertension, atrial fibrillation,
baseline LVEF,baseline Ieftventricular mass, and Pshowed that independent
variables for death were age (risk ratio = 1.061), baseline LVEF (risk ratio
= 0.969}, and P (risk ratio = 0.645). Independent variables for death plus
nonfatal myoeardial infarction were age (risk ratio = 1.060), baseline LVEF
(risk ratio = 0.964), and P (risk ratio = 0.630). Conclusions: In older pts
with heart failure, prior myocardial infarction, and LVEF ? 40Y0 treated with
diuretics plus angiotensin-eonveding-enzyme inhibitors, compared with no
P, P increased LVEF and decreased left ventricular mass, mortality, and
mortality plus nonfatal myocardial infarction.
I 1063-177] Re~p~n~et~P-blockerinElderlYP*tientswith
Severe Heart Failura
M.L. Fisher, S.S. Gottlieb, S.K. Bennett. Urriversityof A4ary/andand
Baffimore VA,Baltimore, MD, USA
Trials of new treatments for patients (pts) with severe chronic heart failure
(CHF) often exclude or have a limited number of elderly subjects, making the
relevance of results to this unique cohort uncertain. In particular, older pts
may respond differently to &blockade than younger pts. Inaddition, clinicians
often avoid f?-blockers in elderly pts because of fear of precipitating CHF.
Hence, we examined tolerance to titrated metoprolol and outcome in a series
of 93 patients (pts) age ? 60 with persistent CHF symptoms despite maximal
standard CHF therapy, NYHA class II = 17, Ill = 35, IV = 37. At baseline,
mean ejection fraction (EF) was 21% + 7%.
In these older, severe CHF pts with a mean age of 67 + 5 years, including
11 pta over 75, metoprolol was well tolerated with only 3 pte (3%) being
intolerant of the drug. Predictably, one year mortality was high (23Yo),but
66 pts (73%) were improved (Jsymptoms and ?EF ? 5) or stable. Overall
frequeneyof marked improvement was40% (32pts), similar toourconcurrent
experience in younger CHFpts and associated with a mean TEF of 18+ 7 (i.e.
mean follow-up EF was 41% in this group). Comparing pts who were stable
or improved to pts who deteriorated (died or were intolerant of metoprolol),
the latter group had lower baseline EF and more severe symptoms (p <
0.05). However, even in the cohort with the most severe CHF (class IV), 12
pte (32%) had mahed improvement.
Our obsenfations suggest that older pts with advanced CHF both tolerate
and often improve with metoprolol. This suppotis the overall safety ofeerefully
titrated p-blocker and justifiea active recruitment of elderly pts for on-going
@-blockerCHFsuwival trials.
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11064-161I Video-AaaiatedCoronaV BYPaasSurgeYWith
internai Mammary Artery: Reauita of a New
Minimaiiy invaaive Surgicai Aiterrtative for
Singie Veaaai Diaeaaa
P.Nataf, L. Lima, F.Jault, S. Benarim, R. Dorent, E. Vaissier,
J.P. Levasseur, A. Pavie, 1.Gandjbakhch. Sce de Chirurgie Cardiaque,
H6pital Piti6, Paris, France
Cliniesi experience with a video-assisted corona!y artery bypass grafting
procedure using the internal mammary artery is reported. The technique
consists of a videoseopic harvesting of the left internal mammary arlery
(LIMA) to revasculartse the left anterior descending artery (LAD) through
a 4 cm left thorecotomy. Between September 1995 and August 1996, we
performed this procedure in 30 patients (Pts) (29 males, 1 female; aged
38-71) with an isolated proximal LAD stenosis (n = 21) or occlusion (n = 9).
All Pts were symptomatic despite appropriate medication. A history of non
transmural myocardial infarction with myocardial viability was found in 9 Pts.
Fourteen Pts had a restenosis after previous PTCA. Mean left ventricular
ejection fraction was 0.61 (< 0.3 in 2 Pts). The LAD-LIMA anastomosis was
performed on the beating heart without cardio-pulmonay bypass (CPB) in 26
Pts. Femoral-femoral CPB was used in 3 Pts becausa unstable angina (n =
1) and intramyoeardial LAD (n = 2). Conversion to aternotomy and standard
CPB was necessary in one Pt for extensive endarterectomy of the LAD.
There were no operative complication and no reoperation for hemorrhage.
Pulmonary infection was observed in 1 Pt and wound infection in 1 Pt. Pts
were ready for discharge on the fifth postoperative day (36 h-13 days).
Control coronary angiography was performed in 17 Pts showing a patent
graft in all cases. An occlusion of the distal segment of the LAD with a
retrograde petfusion of the proximal segment and septal branches by the
LIMA was found in one case. This patient was symptom free and stress test
was negative.Aneetomotic stenosis was noted in 2 Pretreated by angioplasty
(n= 1) and mnventional surgery (n= 1).
In conclusion, the efficiency of this minimally invasive approach should
be prospectively compared to similar reveecularisation with PTCAorsurgieel
approaches using stemotomy with or without CPB.
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M.G. Bouma, J.G. Maessen, P.W.Weerwind, W.A. Buurman. University of
Limburg and Academic Hospital Maastricht, Maastricht, The Netherlands
Beesuse the pathways leading to the systemic inflammatory response after
cardiopulmonary bypass (CPB) resemble those involved in septic shock, we
determined the releasa into the circulation of three proteins that modulate
the toxic effects of Iipopolysaccharide (LPS), during and after CPB in 14
consecutive patients, using either non-coated (n= 7) or heparin-coated (HC,
n : 7) extracaqmreal circuits (ECC). With non-coated ECC, plasma lev-
els of neutrophil-derived bactericidal/perrneability-increasing protein (BPI, A)
peaked direcllyaftercross (X)-clamp release, and declined rapidly thereafter.
This peak was almost completely prevented by HC. Release of LPS-binding
protein (LBP,B) fitted atypical acute phase response pattern, but was not af-
fected by HC. Post-clamp plasma levels of monocyte-derived soluble CD14
(sCD14, C), a protein involved in LPS binding to cells, were significantly
higher with non-coated ECC.
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Conclusions:HC prevents early contact-activation of neutrophils and
monocytes during CPB, but does not affect the acute phase response. Fur-
thermore, these data point to a possible role of LPS toxicity-modulating
proteins in the pathogenesis of the systemic inflammato~ response after
CPB.
= A0.7%D~pSternai Wound infection Rate in
658 Biiaterai Internal Mammary Artery impianta:
Tha Benefit of Avoiding Eiectro Cautery and
Bone Wax
G.E. Cimochowski, M.D. Harostoek, P. Foldes. The Wilkes-Barre Genera/
Hospital, Wilkes-Barre, PA, USA
One of the most serious disadvantages to the routine use of bilateral internal
mammary arteries (BIMA’s) is the reported increased risk of deep sternal
wound infection. We prospectively analyzed this complication in light of
assiduously avoiding electro cautery to control bleeding in any parl of the
periostial edges of the sternum and simultaneously avoiding bone wax in the
marrow. Grp I consisted of 656 consecutive patients (pts) between 10/1/90
and 4/1/96 implanted with bilateral IMA’s (+) veins who were prospectively
analyzed for deep sternal wound infection. A comparison Grp 11,1,809 pts,
operated on between 10/1/90 and 4/1/96 with one IMA (+) veins was used
as a control.
Resu/ts; The pt population did not differ with respect to sex, redo’s,
elective vs emergenciesor peripheral vascular disease. There were statistical
differenceswith respect to age, diabetes, COPD, perfusion time, cross-clamp
